NNZ 2591 - CAS 847952-38-9

NNZ 2591, a synthetic analogue of cyclic glycine-proline (cGP), exhibits oral activity and the ability to cross the blood-brain barrier. This compound demonstrates neuroprotective properties following ischemic brain injury and improves motor function in a rat model of Parkinson's disease. NNZ 2591 holds research potential for ischemic brain injury and Angelman syndrome [1] [2] [3].

847905

C10H14N2O2

194.23

C(C=C)[C@@]12N(C(=O)CNC1=O)CCC2

-20°C

Ice Packs

Peptide